Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy

J Allergy Clin Immunol. 2019 Mar;143(3):1248-1252.e12. doi: 10.1016/j.jaci.2018.10.048. Epub 2018 Nov 14.

¹ Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria; OncoGen Center, County Clinical Emergency Hospital "Pius Branzeu", Timisoara, Romania.
² Vienna Challenge Chamber, Allergy Center Vienna West, Vienna, Austria.
³ OncoGen Center, County Clinical Emergency Hospital "Pius Branzeu", Timisoara, Romania.
⁴ Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria; NRC Institute of Immunology FMBA of Russia, Moscow, Russia; Laboratory for Immunopathology, Department of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russia.
⁵ Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. Electronic address: [email protected].

No abstract available

Publication types